Cargando…
A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer()()
BACKGROUND: Artesunate is an antimalarial agent with broad anti-cancer activity in in vitro and animal experiments and case reports. Artesunate has not been studied in rigorous clinical trials for anticancer effects. AIM: To determine the anticancer effect and tolerability of oral artesunate in colo...
Autores principales: | Krishna, Sanjeev, Ganapathi, Senthil, Ster, Irina Chis, Saeed, Mohamed E.M., Cowan, Matt, Finlayson, Caroline, Kovacsevics, Hajnalka, Jansen, Herwig, Kremsner, Peter G., Efferth, Thomas, Kumar, Devinder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484515/ https://www.ncbi.nlm.nih.gov/pubmed/26137537 http://dx.doi.org/10.1016/j.ebiom.2014.11.010 |
Ejemplares similares
-
The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015) -
Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis
por: Staines, Henry M, et al.
Publicado: (2018) -
The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K(+)-binder Lokelma for maximisation of RAAS inhibition in CKD patients with heart failure
por: Murphy, Daniel, et al.
Publicado: (2021) -
Cardiotoxicity and Cardioprotection by Artesunate in Larval
Zebrafish
por: Zheng, Chuanrui, et al.
Publicado: (2020) -
Intermittent preventive therapy for malaria: arguments in favour of artesunate and sulphamethoxypyrazine - pyrimethamine combination
por: Jansen, Frans Herwig
Publicado: (2011)